Richiebogie
Member
As Ray Peat has pointed out, modern medicine can be slow to adopt new treatments.
However the following argument against Buteyko seemed particularly weak:
https://en.wikipedia.org/wiki/Buteyko_method
My cousin had dreadful asthma in the 80's and then attended a talk or 2 on the Buteyko method in regional Victoria, Australia. That ended his asthma.
I have had asthma on and off throughout my life. I was getting it regularly at night earlier this year. Then after hearing Ray Peat mention Buteyko and CO2 levels I watched a youtube clip on his method which had an Australian narrator. Now when I feel any onset of wheezing I remember to slow my breathing and it disappears!
Perhaps above GINA are talking about the cost of losing returning patients and pharmaceutical sales, rather than the cost of brown paper bags?
However the following argument against Buteyko seemed particularly weak:
https://en.wikipedia.org/wiki/Buteyko_method
An expert guideline by the Global Initiative for Asthma (GINA) noted that results from one study suggested that improvement in symptoms by breathing exercises may be due to causes other than changes in the underlying physiology of the disease, such as relaxation, voluntary reduction in medication use and increased participation of the patient in their own care. This result suggests patients who experience anxiety or who overuse their rescue inhalers in particular may benefit from any breathing techniques as an adjunct to conventional treatments, [highlight=yellow]though cost of using these techniques may be prohibitive[/highlight].
My cousin had dreadful asthma in the 80's and then attended a talk or 2 on the Buteyko method in regional Victoria, Australia. That ended his asthma.
I have had asthma on and off throughout my life. I was getting it regularly at night earlier this year. Then after hearing Ray Peat mention Buteyko and CO2 levels I watched a youtube clip on his method which had an Australian narrator. Now when I feel any onset of wheezing I remember to slow my breathing and it disappears!
Perhaps above GINA are talking about the cost of losing returning patients and pharmaceutical sales, rather than the cost of brown paper bags?